Related Experiment Video

Updated: Jul 7, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

NOD2: a potential target for regulating liver injury

Mathilde Body-Malapel1, Sébastien Dharancy, Dominique Berrebi

  • 1INSERM U795, Lille, France.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|January 30, 2008
PubMed

Insights

NOD2 (nucleotide-binding oligomerization domain-containing protein 2) plays a key role in liver injury. Blocking NOD2 may offer a new therapeutic strategy for liver diseases.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • NOD2 (nucleotide-binding oligomerization domain-containing protein 2) is a bacterial receptor involved in immune system crosstalk.
  • Its role in liver injury mechanisms, particularly concerning innate and adaptive immunity in the digestive tract, remains incompletely understood.
  • Understanding NOD2's function is crucial for advancing liver disease research.

Purpose of the Study:

  • To investigate the role of NOD2 in liver injury.
  • To analyze NOD2 expression and function in both human and murine liver injury models.
  • To explore NOD2 as a potential therapeutic target for liver diseases.

Main Methods:

  • Quantified NOD2, TNF-alpha, and IFN-gamma mRNA via real-time PCR in human and mouse liver samples.
  • Assessed liver injury susceptibility in NOD2-deficient (Nod2-/-) and wild-type mice using concanavalin A (ConA) challenge.
  • Evaluated the impact of muramyl dipeptide (MDP), a NOD2 activator, on ConA-induced liver injury.

Main Results:

  • NOD2, TNF-alpha, and IFN-gamma mRNA were upregulated in liver injury contexts.
  • Nod2-/- mice exhibited resistance to ConA-induced hepatitis, correlating with reduced IFN-gamma production.
  • MDP administration exacerbated ConA-induced liver injury and strongly induced IFN-gamma in immune cells and hepatocytes.

Conclusions:

  • NOD2 contributes to liver injury by modulating immune cell infiltration and hepatocyte responses.
  • NOD2 activation exacerbates liver injury, while its deficiency confers resistance.
  • NOD2 represents a potential therapeutic target for managing liver diseases.

More Related Videos

Use of a Hanging-weight System for Liver Ischemia in Mice05:53

Use of a Hanging-weight System for Liver Ischemia in Mice

Published on: August 7, 2012

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...